Hamad Medical Corporation

Hamad Medical Corporation (HMC) continues to set the standard for excellence in healthcare by fostering a highly skilled clinical workforce. Through a commitment to learning, multidisciplinary collaboration, and adherence to the highest medical standards for its clinical workforce, HMC ensures excellent healthcare delivery for its patients. "At Hamad Medical Corporation, we take immense pride in the caliber of our clinical workforce,” said Dr. Abdullatif Al Khal, Advisor to the Chief Medical Officer. “Our focus on continuous learning, medical education, and professional development ensures that our physicians, nurses, midwives, and allied health professionals remain at the forefront of healthcare excellence. Through structured training programs, international accreditations, and a steadfast focus on patient-centered care, we continue to shape the future of medical education in the region,” added. Dr. Al Khal. As a leading academic medical center, HMC fosters a culture of inquiry, innovation, and knowledge sharing. Physicians and healthcare professionals consistently enhance their expertise by mentoring trainees and managing complex medical cases. This dynamic setting promotes a culture of continuous professional development (CPD), ensuring that clinicians remain at the forefront of medical advancements. HMC delivers a multidisciplinary approach to patient care, integrating the expertise of various specialists to address complex medical conditions. This comprehensive model ensures that diseases such as cancer are managed through a collaborative strategy of a multidisciplinary team involving medical and radiation oncologists, surgeons, nurses, radiologists, and pathologists, among other professionals. By fostering such cooperation, HMC consistently enhances patient outcomes and raises the standard of care. HMC’s commitment to excellence is reinforced by its prestigious international accreditations such as accreditation by the Joint Commission International and by the Accreditation Council for Graduate Medical Education International (ACGME-I). Covering 20 residency programs and 12 fellowship programs, this accreditation ensures that developing physicians receive mentorship from top-tier faculty within a structured academic environment that aligns with the highest international standards. This certification enhances the global recognition of HMC-trained physicians, making them highly respected in healthcare systems worldwide. To read the full press release, visit: https://lnkd.in/dGx4RXw4 #HMC #Healthcare #MedicalEducation #YourHealthOurPriority #Campaign #NursingEducation #Itqan #SpecialistServices #multidisciplinary #SimulationHealthcare #Excellence #Doha #Qatar

Hamad Medical Corporation (HMC) highlighted its ongoing dedication to advancing kidney health through cutting-edge treatments, research, and patient-centered care. The global healthcare community observed World Kidney Day on March 13 2025, a perfect opportunity for HMC to highlight awareness about kidney health as well as an overview of specialized services and treatments. HMC’s kidney services encompassed a comprehensive range of treatments, including advanced dialysis therapies, kidney transplantation, and specialized care for complex kidney conditions. The Corporation’s multidisciplinary team of nephrologists, surgeons, nurses, and support staff worked collaboratively to provide personalized care, ensuring optimal outcomes for patients. "At HMC, we are committed to providing the highest standard of renal care," said Dr. Hassan Al Malki, Head of Nephrology at HMC. "Our state-of-the-art facilities and commitment to continuous improvement enabled us to offer the latest advancements in kidney disease treatment. We were proud of the advancements we made in dialysis, including home dialysis, and the overall management of chronic kidney disease." HMC’s dedication to providing world-class kidney services was evident in its investment in infrastructure, technology, and staff training. This included the recently launched Kidney Transplant Precision Medicine Program, which marked a significant advancement in kidney transplant care, particularly for high-risk patients with hereditary kidney diseases. Additionally, an eight-bed ambulatory dialysis unit was opened in 2024 at Muaither Health Center as part of a joint initiative between HMC and Primary Health Care Corporation (PHCC) to bring life-changing services closer to patients. "World Kidney Day provided a valuable opportunity to raise awareness about the importance of kidney health," Dr. Al Malki added. "We were committed to educating the public about the risk factors for kidney disease and the importance of early detection. By working with our healthcare partners in Qatar to promote healthy lifestyles and regular check-ups, we could help prevent kidney disease and improve the lives of individuals affected by it." Kidney disease can affect people of any age, gender, and race, and it is estimated that one in 10 people in Qatar had some form of kidney impairment. World Kidney Day is a global campaign that spreads knowledge about preventive behaviors, risk factors, and how to live with kidney disease. While early detection allowed for disease care and management, kidney disease-related mortality continued to increase each year. #HMC #Healthcare #KindeyHealth #Nephrology #KidneyTransplant #dialysis #KidneyDisease #Doha #Qatar #RenalCare #WorldKidneyDay2025 #March13

The National Center for Cancer Care and Research (NCCCR) at Hamad Medical Corporation (HMC) has become a leading destination for cancer treatment in the Gulf, attracting patients from across the region while continuing to provide world-class care to Qatar’s local population. With advanced technology, personalized treatment plans, and a highly skilled multidisciplinary team, NCCCR continues to set the benchmark for oncology services. Dr. Mohamed Salem Al-Hassan, Medical Director and CEO of NCCCR and Chair of Corporate Cancer Services at HMC, highlighted the hospital’s growing international reputation: “NCCCR is recognized across the region for its exceptional quality of care and innovative treatments. Patients come to us not only for access to cutting-edge therapies and state-of-the-art facilities but also because of our holistic, patient-centered approach. In 2024, we treated 508 international patients from the region. Our unique combination of expertise, advanced technology, and compassionate care has made us the preferred choice for many patients from the GCC and beyond.” He added, “HMC is a leader in cancer care, offering treatment options that are often unavailable elsewhere in the region. From robotic-assisted surgery to precision medicine and breakthrough target hormone and immunotherapies, our capabilities ensure the best possible outcomes for our patients. While we are honoured to welcome patients from neighbouring countries seeking specialized care, our foremost commitment remains to the people of Qatar, ensuring they receive the highest standard of cancer treatment without the need to travel abroad.” NCCCR provides a full spectrum of cancer care, including Bone Marrow Transplants, cutting-edge Radiation Oncology using technologies like TrueBeam, ETHOS, and CyberKnife, and comprehensive genetic counseling to assess hereditary cancer risks. The center also prioritizes mental health, offering psychotherapy services to support patients throughout their treatment journey. As a regional leader in oncology, NCCCR remains dedicated to advancing cancer care through innovation, research, and continuous improvements, ensuring that both Qatar’s local population and international patients receive the highest standard of treatment available in the region. #HMC #Healthcare #NCCCR #CancerCare #RadiationOncology #TrueBeam #ETHOS #CyberKnife #PrecisionMedicine #CancerHospital #Doha #Qatar

Hamad Medical Corporation congratulates Itqan Clinical Simulation and Innovation Center and their MOU with Qatar Research Development and Innovation Council Qatar Research, Development and Innovation (QRDI) Council. A significant step toward strengthening Qatar’s healthcare research and innovation ecosystem. #Innovation #Healthcare #MedicalEducation #Simulation #HealthcareResearch

Hamad Medical Corporation (HMC) is marking World Glaucoma Week by raising awareness of this serious eye condition and emphasizing the high-quality services it provides for patients with glaucoma. As the leading specialist healthcare provider in Qatar, HMC offers state-of-the-art diagnostic and treatment options to ensure early detection and effective treatment and management of glaucoma, helping to preserve vision and improve the quality of life for patients. Glaucoma is a common eye disease that can lead to irreversible vision loss if not diagnosed and treated in time. It occurs when the optic nerve, which connects the eye to the brain, becomes damaged due to increased pressure in the eye. Dr. Zakia Al Ansari, Consultant Ophthalmologist and Head of the Glaucoma Unit at HMC, explains: “Glaucoma is often called the ‘silent thief of sight’ because it can develop without noticeable symptoms in its early stages. Regular eye examinations are crucial for detecting the condition early and preventing permanent vision loss.” HMC provides comprehensive and world-class care for glaucoma patients – treating more than 500 patients each month, utilizing the latest advancements in ophthalmology. Through its specialized glaucoma clinics, the corporation offers a multidisciplinary approach that includes highly trained specialists, cutting-edge technology, and personalized treatment plans tailored to each patient’s needs. Dr. Al Ansari highlights HMC’s commitment to delivering the highest quality care: “At HMC, we offer a full spectrum of advanced glaucoma treatments, including specialized eye drops, innovative laser procedures, and surgical interventions that help control eye pressure and prevent further vision loss. Our focus is on early detection, effective treatment, and continuous follow-up to ensure the best possible outcomes for our patients.” HMC encourages the public to prioritize their eye health by scheduling regular eye check-ups, especially for individuals at higher risk of glaucoma, including those over 40, individuals with a family history of the disease, previous eye injury, previous ocular surgeries or diseases, people who are of African, Asian or Hispanic descent, and patients with underlying conditions such as diabetes and those who are very nearsighted or far-sighted. HMC recommends that individuals at higher risk of glaucoma should get screened at 35 years of age. A complete eye exam should be repeated every 1 to 3 years, less or more often depending on the level of risk and overall eye health. To read more visit: https://lnkd.in/dKvWzp8K #HMC #Healthcare #Glaucoma #GlaucomaWeek #eyehealth #Doha #Qatar #DrZakiaAlAnsari #eyedisease

Hamad Medical Corporation supports Ms. Mariam Nooh Al Mutawa, Chief Nursing Officer, in her upcoming lecture on: "The Role of Nursing in Islam" Organised by Qatar University's College of Nursing. Qatar University QU Health Sector Employees of HMC are welcome to attend! Thursday 13th March 2025 12.00pm -1.00pm Qatar University- College of Law Building L09 B293 #HMC #healthcare #Nursing #QatarUniversity #NursinginIslam #Ramadan2025 #CollegeofNursing #CorporateNursing #midwifery #MariamAlMutawa #education

All smokers and users of tobacco and nicotine products have been urged by the Tobacco Control Center at Hamad Medical Corporation (HMC) to benefit from the holy month of Ramadan and use it as an opportunity to give up smoking forever. Dr. Ahmed Al-Mulla, Director of the Tobacco Control Center—a World Health Organization (WHO) collaborating center for treating tobacco dependence—stressed that fasting is a great way for smokers to overcome their addiction to tobacco and nicotine products. He emphasized that avoiding smoking for extended periods of time during the day strengthens the self-discipline required to stop smoking and reduces both psychological and physical dependence on nicotine. “The center reports a noticeable yearly increase in the number of smokers attempting to quit during Ramadan, and the therapeutic interventions whether behavioral or medicinal, can greatly increase the chances of successfully stopping permanently,” Dr. Al-Mulla noted. Dr. Jamal Bashi, Smoking Cessation Specialist highlighted the importance of avoiding habits and behaviors that trigger the urge to smoke, such as consuming stimulants or spending time in environments that encourage smoking. He also suggested participating in social and religious activities, drinking plenty of water, using sugar-free gum in the evening, and using miswak during the fasting hours. “Withdrawal symptoms from smoking typically appear only during the first week of Ramadan and that most smokers can overcome them without medical intervention. However, the Tobacco Control Center offers medical help to those who have trouble in stopping smoking,” Dr. Bashi added. Additionally, Dr. Bashi warned against certain harmful behaviors that smokers tend to practice during Ramadan, which can be extremely dangerous to their health. Among these is smoking heavily after breaking fast which raises the risk of heart attacks and strokes and can result in a sudden rise in blood pressure. Furthermore, smoking more cigarettes in the evening increases nicotine addiction, making it more difficult to stop after Ramadan. According to Dr. Al-Mulla, HMC’s Tobacco Control Center offers a wide range of treatments to assist smokers in quitting. These treatments, which are provided through specialized programs that have been scientifically proven to be successful in assisting patients on their path to quitting smoking, include behavioral therapy, medication-based treatment, and laser therapy. Since its establishment, the center has successfully treated thousands of smokers, reducing the health and economic burden on smokers, their families, and the healthcare system. The center encourages all individuals looking to quit smoking to take advantage of its services during the holy month and book an appointment by calling: +974 40254981 or +974 50800959. #HMC #Healthcare #Tobacco #SmokingCessation #TobaccoControlCenter #Doha #WHO #QuitSmoking #Ramadan2025

Hamad Medical Corporation’s (HMC) Hamad Trauma Center has been designated as a World Health Organization (WHO) Collaborating Center on Trauma. This prestigious recognition see the Trauma Center become the third WHO Collaborating Centre at HMC, joining the WHO Collaborating Center for Treating Tobacco Dependence (HMC’s Tobacco Control Center), and the WHO Collaborating Center for Healthy Ageing and Dementia (HMC’s Department of Geriatrics and Long-Term Care). Established in 2007 at Hamad General Hospital as a Level 1 Trauma Center based on the classification of the American College of Surgeons’ Committee on Trauma, the Hamad Trauma Center has since evolved into a leading institution and the anchor of Qatar’s national Trauma System. Since 2014, HMC’s Trauma System has held Trauma Distinction accreditation from Accreditation Canada International, the international accrediting body for trauma systems. Commenting on the achievement, His Excellency Mohammed Bin Khalifa Al Suwaidi, Managing Director of HMC, stated: “The designation of the Hamad Trauma Center as an official WHO Collaborating Center on Trauma is a testament to the excellence of HMC in the field of trauma care. This prestigious recognition underscores our commitment to advancing trauma research, education, and clinical excellence, not only in Qatar but across the region and beyond. Through this collaboration, we will continue to drive innovation, enhance patient outcomes, and contribute to the advancement of global trauma care.” The WHO Collaborating Center on Trauma at HMC will focus on: 1.Supporting WHO in evaluating, upgrading, and strengthening trauma referral pathways. 2.Assisting WHO in developing and disseminating training, educational tools, and standards for trauma management. 3.Contributing to WHO’s efforts to establish a global community of practice on trauma care. To read the full press release visit: https://lnkd.in/d-Sk_T9D #HMC #Healthcare #Trauma #WHO #CollaboratingCenter #Doha #Qatar #TraumaResearch #Milestone #Emergency #HamadTraumaCenter

HMC wishes you all congratulations on the arrival of the holy month of Ramadan! Wishing you many happy returns of this blessed occasion. #HMC #Healthcare #Ramadan2025 #Doha #Qatar

Transforming Medication Management: The Power of Nursing Informatics at Hamad Medical Corporation At Hamad Medical Corporation (HMC), the Nursing Informatics Department (NID) is at the forefront of enhancing patient safety and improving medication management through cutting-edge technology. Key initiatives, such as the implementation of barcode medication administration and infusion pump integration, have streamlined medication delivery, ensuring precision and timeliness. A major achievement is the development of our Closed Loop Medication Administration System (CLMAS), which seamlessly connects prescribing, dispensing, and administration to minimize errors and elevate care standards. Additionally, our E-Taleem platform empowers healthcare professionals with continuous learning opportunities, fostering growth in the field of Nursing Informatics. This is a testament to HMC’s commitment to integrating technology, education, and data-driven strategies for safer, more efficient patient care. The department also drives continuous improvement through data analytics, offering compliance metrics and actionable insights that lead to measurable progress. As of December 2024, our high patient and medication scanning rates reflect our unwavering focus on safety and quality care. Through these advancements, Nursing Informatics continues to create a culture of excellence, transforming medication management, and prioritizing patient safety at HMC. #HMC #NursingInformatics #PatientSafety #MedicationManagement #HealthcareInnovation #HamadMedicalCorporation #TechInHealthcare #QualityCare